Potential biochemical markers of chronic bronchitis and bronchial asthma. Current state of the problem

The literature review, according to recent publications, systematizes modern ideas about new biochemical markers of bronchopulmonary pathology, namely chronic obstructive pulmonary disease, chronic bronchitis and bronchial asthma. Information on potential biochemical markers associated with patholog...

Full description

Bibliographic Details
Main Authors: E. A. Kurtukov, Yu. I. Ragino
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Siberian Branch Publishing House 2020-01-01
Series:Сибирский научный медицинский журнал
Subjects:
Online Access:https://sibmed.elpub.ru/jour/article/view/306
_version_ 1797269585683021824
author E. A. Kurtukov
Yu. I. Ragino
author_facet E. A. Kurtukov
Yu. I. Ragino
author_sort E. A. Kurtukov
collection DOAJ
description The literature review, according to recent publications, systematizes modern ideas about new biochemical markers of bronchopulmonary pathology, namely chronic obstructive pulmonary disease, chronic bronchitis and bronchial asthma. Information on potential biochemical markers associated with pathology of the bronchopulmonary system is presented: pulmonary activation regulated chemokine (chemokine ligand CCL20), surfactant proteins A and D, pentraxin-3, defensins, alpha-1 antitrypsin, Clara cell protein, interleukin-19, resistin-like molecules. For each biomolecule, its characteristic, biological properties and effects are described, as well as the results of experimental and clinical studies of its effects in bronchopulmonary pathology, the association of elevated blood levels of a biomolecule with clinical manifestations of diseases. It is concluded that today there are a considerable number of new potential biomarkers of the respiratory system diseases for early and effective diagnosis, prevention and treatment of diseases, however, the effects of some of them are either insufficiently studied or contradictory and require further research, which is actively ongoing in the whole world and in Russia.
first_indexed 2024-03-08T14:33:49Z
format Article
id doaj.art-3660ae0b8ff7416d896c66638a615966
institution Directory Open Access Journal
issn 2410-2512
2410-2520
language Russian
last_indexed 2024-04-25T01:50:43Z
publishDate 2020-01-01
publisher Russian Academy of Sciences, Siberian Branch Publishing House
record_format Article
series Сибирский научный медицинский журнал
spelling doaj.art-3660ae0b8ff7416d896c66638a6159662024-03-07T18:49:58ZrusRussian Academy of Sciences, Siberian Branch Publishing HouseСибирский научный медицинский журнал2410-25122410-25202020-01-0139651310.15372/SSMJ20190601214Potential biochemical markers of chronic bronchitis and bronchial asthma. Current state of the problemE. A. Kurtukov0Yu. I. Ragino1Evgeniy Alekseevich Kurtukov 630089, Novosibirsk, Boris Bogatkov str., 175/1Research Institute of Internal and Preventive Medicine -Branch of the Institute of Cytology and Genetics of SB RASThe literature review, according to recent publications, systematizes modern ideas about new biochemical markers of bronchopulmonary pathology, namely chronic obstructive pulmonary disease, chronic bronchitis and bronchial asthma. Information on potential biochemical markers associated with pathology of the bronchopulmonary system is presented: pulmonary activation regulated chemokine (chemokine ligand CCL20), surfactant proteins A and D, pentraxin-3, defensins, alpha-1 antitrypsin, Clara cell protein, interleukin-19, resistin-like molecules. For each biomolecule, its characteristic, biological properties and effects are described, as well as the results of experimental and clinical studies of its effects in bronchopulmonary pathology, the association of elevated blood levels of a biomolecule with clinical manifestations of diseases. It is concluded that today there are a considerable number of new potential biomarkers of the respiratory system diseases for early and effective diagnosis, prevention and treatment of diseases, however, the effects of some of them are either insufficiently studied or contradictory and require further research, which is actively ongoing in the whole world and in Russia.https://sibmed.elpub.ru/jour/article/view/306chronic obstructive pulmonary diseasebronchial asthmabiochemical markerspulmonary activation regulated chemokinesurfactant protein asurfactant protein dpentraxin-3defensinalpha-1 antitrypsininterleukin-19macrophage inflammatory protein
spellingShingle E. A. Kurtukov
Yu. I. Ragino
Potential biochemical markers of chronic bronchitis and bronchial asthma. Current state of the problem
Сибирский научный медицинский журнал
chronic obstructive pulmonary disease
bronchial asthma
biochemical markers
pulmonary activation regulated chemokine
surfactant protein a
surfactant protein d
pentraxin-3
defensin
alpha-1 antitrypsin
interleukin-19
macrophage inflammatory protein
title Potential biochemical markers of chronic bronchitis and bronchial asthma. Current state of the problem
title_full Potential biochemical markers of chronic bronchitis and bronchial asthma. Current state of the problem
title_fullStr Potential biochemical markers of chronic bronchitis and bronchial asthma. Current state of the problem
title_full_unstemmed Potential biochemical markers of chronic bronchitis and bronchial asthma. Current state of the problem
title_short Potential biochemical markers of chronic bronchitis and bronchial asthma. Current state of the problem
title_sort potential biochemical markers of chronic bronchitis and bronchial asthma current state of the problem
topic chronic obstructive pulmonary disease
bronchial asthma
biochemical markers
pulmonary activation regulated chemokine
surfactant protein a
surfactant protein d
pentraxin-3
defensin
alpha-1 antitrypsin
interleukin-19
macrophage inflammatory protein
url https://sibmed.elpub.ru/jour/article/view/306
work_keys_str_mv AT eakurtukov potentialbiochemicalmarkersofchronicbronchitisandbronchialasthmacurrentstateoftheproblem
AT yuiragino potentialbiochemicalmarkersofchronicbronchitisandbronchialasthmacurrentstateoftheproblem